ATE408843T1 - Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin - Google Patents

Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin

Info

Publication number
ATE408843T1
ATE408843T1 AT02080462T AT02080462T ATE408843T1 AT E408843 T1 ATE408843 T1 AT E408843T1 AT 02080462 T AT02080462 T AT 02080462T AT 02080462 T AT02080462 T AT 02080462T AT E408843 T1 ATE408843 T1 AT E408843T1
Authority
AT
Austria
Prior art keywords
present
hapten
aforementioned
mdma
methylenedioxymethamphetamin
Prior art date
Application number
AT02080462T
Other languages
English (en)
Inventor
Robert Ivan Mcconnell
El Ouard Benchikh
Stephen P Fitzgerald
John Victor Lamont
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE408843T1 publication Critical patent/ATE408843T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02080462T 2001-12-20 2002-12-17 Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin ATE408843T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01205058 2001-12-20

Publications (1)

Publication Number Publication Date
ATE408843T1 true ATE408843T1 (de) 2008-10-15

Family

ID=39777868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02080462T ATE408843T1 (de) 2001-12-20 2002-12-17 Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin

Country Status (6)

Country Link
US (2) US7217802B2 (de)
EP (1) EP1321772B1 (de)
CN (1) CN1281626C (de)
AT (1) ATE408843T1 (de)
DE (1) DE60228927D1 (de)
ES (1) ES2316520T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316520T3 (es) * 2001-12-20 2009-04-16 Randox Laboratories Ltd. Metodo y conjunto para detectar, o determinar, la 3,4-metilenodioximetanfetamina.
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
US7060847B2 (en) * 2003-07-18 2006-06-13 Roche Diagnostics Operations, Inc. Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
US7022492B2 (en) 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7037669B2 (en) 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7115383B2 (en) 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
GB201313938D0 (en) 2013-08-05 2013-09-18 Randox Lab Ltd Immunoassay for phenethylamines of the 2C and DO sub-families
GB201409516D0 (en) 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
CN114890958B (zh) * 2022-02-23 2023-10-20 四川警察学院 双光子染料化合物、其制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US6207396B1 (en) * 1995-11-20 2001-03-27 Microgenics Corporation Immunoassay reagents and methods for determination of LSD and LSD metabolites
DE19630102A1 (de) * 1996-07-25 1998-01-29 Boehringer Mannheim Gmbh Neue aktivierte Amphetamine
GB2361473C (en) * 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
ES2316520T3 (es) * 2001-12-20 2009-04-16 Randox Laboratories Ltd. Metodo y conjunto para detectar, o determinar, la 3,4-metilenodioximetanfetamina.
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens

Also Published As

Publication number Publication date
US7217802B2 (en) 2007-05-15
EP1321772B1 (de) 2008-09-17
DE60228927D1 (de) 2008-10-30
CN1281626C (zh) 2006-10-25
CN1429844A (zh) 2003-07-16
HK1053700A1 (en) 2003-10-31
US20040121400A1 (en) 2004-06-24
US20090280499A1 (en) 2009-11-12
EP1321772A1 (de) 2003-06-25
ES2316520T3 (es) 2009-04-16

Similar Documents

Publication Publication Date Title
DE69033796D1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
ATE496917T1 (de) Haptene, immunogene, antikörper und konjugate für 2-oxo-3-hydroxy lsd
ATE408843T1 (de) Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin
DE60335428D1 (de) Immunogene, Antikörper und Konjugate für Ketamin und dessen Metaboliten
ATE256658T1 (de) Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25- dihydroxy-vitamin-d
EE200300128A (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
DE69831601D1 (de) Testkit und verfahren zum nachweis eines analyten
ATE351921T1 (de) Verfahren für fluoreszenzerkennungstest
DE69839245D1 (de) Verfahren zur Erfassung der Information einer Programmführung, geeignetes Programmführungsverfahren und Programmführungsvorrichtung
DE60207016D1 (de) Verfahren und Kit zur Quantifizierung von Beta-Laktam Penizillinen
ATE456799T1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
ATE376675T1 (de) Ein verfahren zur differentiellen markierung mittels platin-komplexen
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE284034T1 (de) Verfahren zum nachweis von protein s
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE336724T1 (de) Verfahren zum testen auf morbus crohn und testkit dafür
ATE135746T1 (de) Enzymatisches verfahren zur bestimmung der analyt-konzentration
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
DE50207850D1 (de) Biosensor und verfahren zum erfassen von nukleinsäuren mittels mindestens zwei einheiten zum immobilisieren von nukleinsäuren
ATE195809T1 (de) Verfahren zum nachweis metabolisch markierter dna
DE602005023784D1 (de) Blockierter enzymsondenkomplex
DE69922680D1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee